Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

461

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Cancer of the Rectum
Interventions
DRUG

mFolfirinox

Investigational arm: Neoadjuvant chemotherapy mFolfirinox, 4 cycles: oxaliplatin: 85 mg/m² in 2 hours at D1 irinotecan: 180 mg/m² in 90 min at D1 folinic acid: 400 mg/m² simultaneously in 2 hours at D1 during the irinotecan infusion 5-FU: 2400 mg/m² continuous infusion during 48 hours (1200 mg/m² at D1 and D2), every 14 days during 2 months (4 cycles), then CRT (50 Gy (2 Gy/session, 25 fractions) + capecitabine 800 mg/m² twice a day 5 days/7), then surgery with TME 6-8 weeks after chemoradiation, and 4 months of adjuvant CT depending on the center's choice.

RADIATION

Radiotherapy 50 Gy

5 radiations per week of 2 Gy for 5 weeks

DRUG

Capecitabine

1600 mg/m² (800 mg/m² twice daily) for 5 weeks

PROCEDURE

TME surgery

DRUG

mFolfox6 or capecitabine

oxaliplatine 85 mg/m² (day 1 of cycle; perfusion in 2h), folinic acid 400 mg/m² (day 1 of cycle perfusion in 2h), 5-FU (bolus 400 mg/m² in 10 min and 2400 mg/m² perfusion continuous 46h). Arm A - 12 cycles ; Arm B - 6 cycles OR Capecitabine 2500 mg/m²/day (Each cycle consists of 1250 mg/m² twice daily for D1-14 then pause therapeutic from D15-21). Arm A - 8 cycles; Arm B 4 cycles.

Trial Locations (36)

Unknown

Centre hospitalier Universitaire d'Amiens, Amiens

ICO - Site Paul Papin, Angers

Centre hospitalier d'Auxerre, Auxerre

Centre Hospitalier de Beauvais, Beauvais

Institut de Cancérologie de Franche Comté, Besançon

Centre Hospitalier de Blois, Blois

Hopital Avicenne, Bobigny

Clinique Tivoli, Bordeaux

Hopital Saint Andre, Bordeaux

Institut Bergonie, Bordeaux

Centre Francois Baclesse, Caen

Chd de La Roche Sur Yon - Les Oudairies, La Roche-sur-Yon

Centre Bourgogne, Lille

Centre Oscar Lambret, Lille

Centre Léon Bérard, Lyon

Hopital Prive Jean Mermoz, Lyon

Ap Hm - Hopital de La Timone - Adultes, Marseille

Institut de Cancérologie de Franche Comté, Montbéliard

Centre Azuréen de cancérologie, Mougins

Hopital Emile Muller, Mulhouse

centre Alexis Vautrin, Nancy

Polyclinique de Gentilly, Nancy

Centre Antoine Lacassagne, Nice

Groupe Hospitalier La Pitie-Salpetriere, Paris

Institut Mutualiste Montsouris, Paris

Hopital Haut Leveque, Pessac

Centre Hospitalier Regional D'Annecy, Pringy

Hopital Robert Debre, Reims

Institut Jean Godinot, Reims

Clinique Armoricaine de Radiologie, Saint-Brieuc

Hopital Saint Gregoire, Saint-Grégoire

ICO - Site René Gauducheau, Saint-Herblain

Clinique Mutualiste de L'Estuaire, Saint-Nazaire

Centre Hospitalier de la Réunion - Site du GHSR, Saint-Pierre

Centre Paul Strauss, Strasbourg

Gustave Roussy, Villejuif

All Listed Sponsors
lead

UNICANCER

OTHER

NCT01804790 - Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | Biotech Hunter | Biotech Hunter